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The population of end-stage renal disease (ESRD) patients is
rising all over the world.1,2 In 2009, more  than 350,000 patients
in the United States (US) received in-centre haemodialy-
sis (HD). Vascular access procedures are one of the most
commonly performed surgeries in the US, with approxi-
mately 500,000 procedures performed annually.3 Treating
ESRD patients cost the US over $40 billion in public and
private funds in 2009.4 In Europe, more  than 550,000 ESRD
patients received renal replacement therapy (RRT) in 2010.5
The prevalence of RRT per million population (p.m.p.) on
31st December 2009 was the highest in Portugal (1507 p.m.p.),
Belgium, French-speaking (1193 p.m.p.) and Spain, Catalonia
(1160 p.m.p.).6
Despite an increase in the number of kideny transplants,
which is the best treatment of ESRD patients, chronic HD is
still the main therapy.1 Autologous (native) arteriovenous ﬁs-
tula (AVF) provides the best access to the circulation because
of low complication rate, long-term use and lower costs,
compared to arteriovenous graft (AVG) and central venous
catheter (CVC).1,7,8 The cost of vascular access care was
more than ﬁve times lower in those who had begun treat-
ment with functioning AVF, compared to those who were
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treated with a graft or permanent catheter.9 The main fac-
tor limiting ﬁstula use is a high rate (up to 70%) of primary
failure.10 To avoid unsuccesful attenpts, guidelines recom-
mend preoperative duplex ultrasonography (DUS) and the
use of vessels with a diameter able to maintain sufﬁcient
blood ﬂow and ﬁstula maturation.1,7,8 The impact of vessel
diameter was evaluated in numerous studies.11–14 In some
studies, artery and vein diameters below 2 mm were predictors
of high incidence of early thrombosis or failure of matura-
tion, and some authors recommend to set a cut-off size of
the artery and the vein. The most widely mentioned rec-
ommendation is: artery diameter ≥2 mm and vein diameter
≥2.5 mm15–18 or vein diameter ≥3 mm.19 After anastomosis
construction, an increase of ﬂow (10–20 times) and vessels
dilatation are necessary to be functional. The quality of the
vessels is also important and some studies underline that the
capacity of vessels’ dilatation (vascular compliance) is more
important than the vessel diameter alone.20–22 There is no
simple and reliable test for determining vascular compliance
preoperatively. The predictive value of the arterial resistance
index (RI) is uncertain.7 In one study, preoperative RI > 0.7 in
the feeding artery indicates that arterial blood ﬂow will not
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increase sufﬁciently, thus reducing the chance of success-
ful AVF.23 Two other studies found no difference in ﬁstula
outcome for hyperaemic response.18,24 Preoperative venous
size and, especially, vein distensibility are also difﬁcult to
measure.25 Planken et al. revealed daily variations in forearm
venous diameters, which should be taken into account when
deﬁning cut-off diameters prior to vascular access surgery.26
Lockhart et al. recommended using a venous tourniquet in
preoperative DUS which increases the number of patients eli-
gible for forearm ﬁstulas without decreasing the adequacy
rate.27
In some studies, older age was a predictor of ﬁstula
failure,10,18,28,29 but other authors did not ﬁnd this relation-
ship between age and failure of ﬁstula.30,31 A lower percent
of functional AVFs was found in females.18,19,28,32 Further-
more,  some studies found no differences in ﬁstula success
regarding gender.31,33 Diabetic patients were marked as one of
the risk groups of patients.34,35 In contrast, there was no neg-
ative correlation regarding diabetes and AVF success in some
studies.36–38
In an ideal situation, patients should be referred to a
surgeon a few months before starting HD. A detailed med-
ical history (presence of diabetes, hypertension, peripheral
ischaemia, amputation, coronary or carotid surgery, pace-
maker, stroke, cannulation of the central veins etc.) and
physical examination of the both upper extremities are nec-
essary. Blood pressure measurement on both arms may reveal
proximal artery stenosis if there is more  than 20 mmHg  dif-
ference. Arterial pulses, Allen test, patency of the deep and
superﬁcial veins should be checked. According to the current
guidelines, preoperative DUS should be performed and, if pos-
sible, vein mapping as well. DUS is especially important in
those cases of invisible superﬁcial veins, atherosclerotic dis-
ease and prior cannulation of the central vein. Some authors
recommend that DUS evaluation should be performed by the
surgeon constructing the AVF.39,40
Who  should  perform  angioaccess  surgery?
The surgical challenge is to successfully create a functioning
arteriovenous access suitable for HD therapy.41 Angioaccess
surgery is not restricted to vascular surgeons. All over the
world, other specialists also perform this operation (urol-
ogists, general and cardiothoracic surgeons). A common
“conversation piece” among most nephrologists is the frustra-
tion they face in feeling at the mercy  of the surgeon(s) in their
institution.42 Ortega Suárez stated that one of possible reasons
why graduate doctors in Spain were less and less interested in
choosing nephrology was dependence on other departments
(e.g. vascular surgery).43 In the study of Roca Tey, more  than
half of the HD centres considered the support from the sur-
gical services to be insufﬁcient.44 Because of the surgeons’
disinterest, nephrologists from some centers started to cre-
ate AVFs.35 They construct about 85% of the AVFs in Italy and
about 25% of the AVFs in Japan.45 The nephrologist group in
one centre in Spain achieved results comparable to the sur-
gical group regarding the percentage of primary failures and
AVFs survival. The waiting time for surgery was reduced from
103 days in general surgery group to 21.5 days in nephrology
group. The percentage of patients initiating dialysis without
an AVF was also reduced from 63% in general surgery group to
19% in nephrology group.46
According to Davidson et al., the issue is not who places
the access, but who does it right.47 Vascular access proce-
dures should be restricted to surgeons with demonstrable
interest and experience, and o those that are familiar with
the basic principles of HD and the problems of patients on
HD. All required surgical procedures have to be on the sur-
geons’ repertoire, especially follow up after interventions and
dealing with complications. Vascular surgeons seem to be the
best option in these circumstances. There are also opposite
opinions. Jiménez-Almonacid et al. reported that angioaccess
surgery, as an outpatient surgery, was included in the general
surgery unit and was performed by not exclusively dedicated
surgeons.48 In some centres, vascular access procedures are
considered to be minor procedures and are entrusted to junior
surgeons.49 Access operations should not be the tail-light of
the schedule in the operating theatre because time pressure
prevents meticulous and patient surgery.50
The  role  of  surgical  experience  and  dedication
to  angioaccess  surgery
It is estimated that 25% of all patients starting HD will die
because of an inadequate vascular access.51 This information
must be a warning to all participants involved in the care of
ESRD patients. The relative risk of death increases by two to
three times in case the patients started dialysis with CVC,
compared to those using an arteriovenous access.52 Long-term
dialysis with tunnelled cuffed catheters is associated with
a two-fold to three-fold increase in the death risk, a ﬁve to
ten-fold increased risk of a serious infection, increased hos-
pitalization days, decreased likelihood of adequate dialysis
and an increased number of vascular access procedures.53 The
use of tunnelled catheter at any time is associated with an
increased risk of death. This effect increases with the duration
of catheterisation.54 Therefore, special effort should be made
to avoid CVC as much as possible.55 Goodkin et al. concluded
that the greater use of catheters/AVGs and markedly lower use
of ﬁstulas in the US may be killing patients.56 Nephrologists
and surgeons are ethically obligated to systematically explain
to patients the harms of tunnelled cuffed catheters.53
Many authors agree that the surgical skill is one of
the important factors affecting AVF surgery success.44,49,57–59
Numerous studies revealed surgical experience as a sta-
tistically signiﬁcant predictor of success in angioaccess
surgery.60–63 Puskar and al. have shown that insufﬁcient sur-
gical experience contributed to AVF failure.64 Huijbregts et al.
concluded that the probability of primary failure is strongly
related to the centre of access creation, suggesting an impor-
tant role for the vascular surgeon’s skill and decisions.65 The
great variability in results regarding vascular access was found
in a single autonomous community, with an almost uniform
management model. The authors concluded that the results
depended on the type of centre where the patient underwent
dialysis, the vascular radiology service, and especially the sur-
gical service responsible for the vascular access.66 In the study
of O’Hare et al. (n = 1114), AVF placements were more  than
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three times greater at high volume centres (>30 procedures per
year) than at low volume centres.67 Fassiadis et al. suggested
that the placement of AVF should be performed by the most
experienced member of a team dedicated to vascular access
creation, or at least under their supervision.68
There are also opposite opinions. Data reported by Gun-
devia et al. and Weale et al. suggest that trainees are
able to perform AVF procedures effectively with adequate
supervision and allocation of appropriate cases. The ﬁstula
patency did not differ after creation by trainees as opposed
to creation by senior consulting surgeons in those two single-
centre studies.69,70 Weale et al. suggest that vascular access
surgery can be utilized as a training operation.70 Strong oppo-
site ﬁndings were found by the Chemla’s team in London.
They performed 552 AVFs in 4 years and found that the
results of experienced consultant were superior to that of the
junior surgeons performing surgery under his direct super-
vision. The primary success rate in the consultant group
and junior surgeon group was 94.2% and 81%, respectively
(p < 0.01). Furthermore, primary and secondary patency rates
at 22 months showed statistical difference (p < 0.025) between
the two groups as well.68 During the analysis of AVF ver-
sus AVG use among new HD patients in Europe and the
US, Pisoni et al. found that the likelihood of the AVF use
was 40% lower in dialysis unit in which surgery trainee
either performed or assisted permanent vascular access
placements.63
The impact of haemodialysis vascular access training was
researched in the Dialysis Outcomes and Practice Patterns
Study (DOPPS). In the DOPPS the risk of primary ﬁstula failure
was 34% lower when ﬁstulas were placed by surgeons who had
created at least 25 ﬁstulas during training (P = 0.002). In the US
54% of access surgeons responded that degree of emphasis
given to creating arteriovenous vascular access was “not at
all emphasized” or “somewhat emphasized” compared with
other surgical training.71 In contrast, only 13% of the operators
in Japan and 16% in Italy, the nations with the highest preva-
lences of ﬁstulas, gave either of the two responses indicating
low training emphasis on access surgery.56
The surgeon should put additional time and effort into con-
structing a functional ﬁstula in the ﬁrst attempt. In the study
of Canadian authors with a large number of patients (n = 5924),
second access creation was associated with an increased risk
of sepsis. Early access creation (at least 4 months before start-
ing HD) was associated with a 43% of reduction in the risk of
sepsis and a 24% reduction in the risk of death.72 Patients with
a history of failed access had 2.56 times the risk of failure com-
pared with patients with a ﬁrst access in one study.73 In the
study of Rodriguez et al., two-thirds of patients in whom the
ﬁrst AVF developed successfully did not have any subsequent
failure, whereas initial failure increased the risk of subsequent
failure by a factor of 2–8.57
Asif et al. have shown that 90% of the patients with CVC and
previously failed arteriovenous access, who were evaluated
with vascular mapping, had suitable veins for the construc-
tion of an AVF. Despite aggressive educational efforts, 37%
of patients with CVC refused permanent access surgery in
that study.41 Other authors also mentioned that patients were
prone to refusing surgery after failed prior access.44,74,75 Oper-
ator’s experience is also important in other VA procedures.
In the catheter use, the implantation team (nephrologist, sur-
geon, nurse) is more  important for results than the technique
of implantation.76
Despite preoperative DUS, intraoperative exploration still
remains crucial. Saucy et al. state that intraoperative surgi-
cal assessment of the vessels is the last possibility to choose
the right strategy.17 Lauvao et al. stress that surgeon’s judge-
ment remains extremely important.37 Konner underlines that
a vascular access surgeon has to be aware of the anatomi-
cal, physiological, haemodynamic, and mechanical principles
underlying the procedure and this has to be combined with
manual skills, experience and creativity. Even minimal errors,
for example, minor narrowing in the beginning of the anasto-
mosed vein, will eventually translate into late stenosis. Thus,
not only early, but also late failure reﬂects on the quality of
the vascular access surgeons.77 Nephrologists should strive to
build a strong relationship with a limited number of access
surgeons and the choice of access surgeon must be driven
by the outcome, and be independent of economics and local
politics.41,78–80 Nguyen et al. suggest that surgery continuous
quality improvement data on AVF outcome should help with
surgeon selection, based on the ability to create a mature AVF
in >50% of patients.79
Vascular  access  education
Constant effort should be put into continuous education
of all participants involved in the care of ESRD patients.
In order to increase interest and the understanding of the
need for autologous AVF, patients should be exposed to large
amounts of discussion and persuasion. Pre-dialysis patients
have to take an active role in the defence against unneces-
sary venipuncture.81 The implementation of a vascular access
quality programme has improved access care and resulted
in placement of more  autogenous AVFs.75,82,83 Education of
all the members in the multidisciplinary team (including
patients, their families or caregivers and family doctors) and
the implementation of an optimized care protocol are espe-
cially important in centres with a low rate of native AVF and
a high rate of primary failure. In a large scale multi-centre
study of Nguyen et al., it was reported that the success of
the sponsored multidisciplinary educational meetings was
indicated by a dramatic increase in AVF use, without substan-
tially increasing catheter use.79 Establishing of vascular access
centres (VAC) with dedicated and educated multidisciplinary
access team provides the best access care. In the study of Mish-
ler et al. dedicated outpatient VAC decreases hospitalization
and missed outpatient dialysis treatments.84
Conclusion
Angioaccess procedures should not be considered as minor
procedures. These operations must be restricted to surgeons
with demonstrable interest and experience, or they should at
least be carried out under their supervision. Preoperative DUS
evaluation should become a routine tool for all vascular access
surgeons. Vascular surgeons should be involved in vascular
access care as much as possible. Constant effort should be put
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into continuous education of all participants involved in the
care of ESRD patients.
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